Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 56 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/20/24
End: 09/30/26
Due: 09/30/27
Phase: N/A
Priority: Normal
Start: 09/21/20
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 03/29/19
End: 05/31/24
Due: 05/31/25
Phase: N/A
Priority: Normal
Start: 01/30/20
End: 12/31/23
Due: 12/31/24
A Safety and Feasibility Study of IS-001 Injection in Patients Undergoing Robotic Colorectal Surgery
Phase: N/A
Priority: Normal
Start: 06/14/23
End: 04/04/24
Due: 04/04/25
Phase: N/A
Priority: Normal
Start: 07/15/23
End: 12/30/27
Due: 12/30/28
Phase: N/A
Priority: Normal
Start: 09/30/24
End: 08/31/25
Due: 08/31/26
Phase: N/A
Priority: Normal
Start: 01/17/24
End: 07/31/25
Due: 07/31/26
Phase: N/A
Priority: Normal
Start: 03/26/21
End: 12/30/29
Due: 12/30/30
Phase: N/A
Priority: Normal
Start: 07/31/25
End: 10/31/29
Due: 10/31/30
Phase: N/A
Priority: Normal
Start: 07/20/22
End: 07/31/28
Due: 07/31/29
Phase: N/A
Priority: Normal
Start: 06/30/10
End: 10/31/13
Due: 10/31/14
Phase: N/A
Priority: Normal
Start: 09/30/13
End: 03/31/17
Due: 03/31/18
Phase: N/A
Priority: Normal
Start: 09/18/20
End: 08/31/23
Due: 08/31/24
Phase: N/A
Priority: Normal
Start: 11/01/21
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 03/12/19
End: 10/25/22
Due: 10/25/23
Phase: N/A
Priority: Normal
Start: 03/17/20
End: 06/30/24
Due: 06/30/25
Phase: N/A
Priority: Normal
Start: 07/31/11
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 10/25/23
End: 03/31/28
Due: 03/31/29
Phase: N/A
Priority: Normal
Start: 02/01/18
End: 07/24/23
Due: 07/24/24
Phase: N/A
Priority: Normal
Start: 06/03/21
End: 11/30/28
Due: 11/30/29
Phase: N/A
Priority: Normal
Start: 04/17/17
End: 12/26/17
Due: 12/26/18
Phase: N/A
Priority: Normal
Start: 04/01/20
End: 03/30/24
Due: 03/30/25
Phase: N/A
Priority: Normal
Start: 07/06/23
End: 05/21/24
Due: 05/21/25
Phase: N/A
Priority: Normal
Start: 05/31/10
End: -
Due: -